Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

Cardiologists join the FDA’s fight against menthol cigarettes, flavored cigars

The American College of Cardiology (ACC), Association of Black Cardiologists, American Heart Association and Society for Cardiovascular Angiography & Interventions are just some of the healthcare organizations supporting the FDA's proposal.

Hospitals’ labor costs jump by one-third

Healthcare executives may need to do some creative thinking to manage the shrinking margins and labor shortages currently being seen throughout the industry. 

Kaiser Permanente reports nearly $1B loss over COVID surge

California-based health system Kaiser Permanente was slammed by a surge in COVID-19 cases during the first quarter of 2022, playing a role in a nearly $1 billion loss in the first three months of the year.

FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk

The move limits the vaccine to individuals 18 and older for whom other other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as those 18 and older who would otherwise not receive a COVID-19 vaccine.

The USPSTF changed the low-dose aspirin recommendations for cardiovascular disease prevention in April 2022 by suggesting patients over age 60 without history of CVD should not take it and people 40-60 should only take it if there are other risk factors.

VIDEO: USPSTF official discusses new low-dose aspirin recommendations

Michael J. Barry, MD, vice chair of the U.S. Preventive Services Task Force, gave Cardiovascular Business an overview of the new recommendations.

coronavirus COVID-19 vaccine vaccination

Severe COVID-19 ages the brain 20 years

"We urgently need to look at what can be done to help these people," one researcher said. 

Hospital finance

Margins are improving, but hospitals face a long road to recovery from the COVID-19 pandemic

Hospital and health systems saw incremental economic improvements in March, with rising margins and fewer COVID-19 cases and hospitalizations. 

Thumbnail

Unpaid student loan debt is bad for the heart

An American Journal of Preventive Medicine study highlights higher rates of cardiovascular disease for adults who fail to pay down student debt.

Displaying 417 - 424 of 714

Around the web

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

AI in Healthcare
Healthcare AI regulation needs nuance, balance: Research review

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.